Who
Joseph C. Galante
Director
Company insider
Files Form 4 as: Director, Cumberland Pharmaceuticals; Director, Pinnacle Financial Partners; Director, Avenue Financial Holdings.
In numbers
- Trades disclosed
- 534
- Buys
- 463
- Sells
- 1
- Bought
- $546K
- Sold
- $296K
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 9 Feb 2015
- Last trade
- 18 Mar 2026
- Last filed
- 20 Mar 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month. 1 lines have no legible date and are left out.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 18 Mar 2026filed 20 Mar 2026 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code A | $5,0401,800 at $2.80 | filing |
| 18 Mar 2026filed 20 Mar 2026 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code A | $5,0401,800 at $2.80 | filing |
| 17 Mar 2025filed 18 Mar 2025 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code A | $5,1701,000 at $5.17 | filing |
| 25 Mar 2024filed 30 Jan 2025 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code A | $4,2752,500 at $1.71 | filing |
| 25 Mar 2024filed 26 Mar 2024 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code A | $1,7101,000 at $1.71 | filing |
| 1 Mar 2024filed 4 Mar 2024 | Pinnacle Financial Partners | SEC FORM 4 Code F | $20K239 at $82.72 | filing |
| 1 Mar 2024filed 4 Mar 2024 | Pinnacle Financial Partners | SEC FORM 4 Code A | —989 at $0.00 | filing |
| 24 Mar 2023filed 27 Mar 2023 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code A | $1,9201,000 at $1.92 | filing |
| 1 Mar 2023filed 2 Mar 2023 | Pinnacle Financial Partners | SEC FORM 4 Code F | $13K174 at $74.09 | filing |
| 1 Mar 2023filed 2 Mar 2023 | Pinnacle Financial Partners | SEC FORM 4 Code A | —1,084 at $0.00 | filing |
| 20 Jan 2023filed 23 Jan 2023 | Pinnacle Financial Partners | SEC FORM 4 Bought | $72K1,000 at $72.26 | filing |
| 21 Dec 2022filed 23 Dec 2022 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $400180 at $2.22 | filing |
| 20 Dec 2022filed 23 Dec 2022 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $462200 at $2.31 | filing |
| 19 Dec 2022filed 23 Dec 2022 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $553250 at $2.21 | filing |
| 16 Dec 2022filed 23 Dec 2022 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $222100 at $2.22 | filing |
| 15 Dec 2022filed 23 Dec 2022 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $13460 at $2.24 | filing |
| 14 Dec 2022filed 23 Dec 2022 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $265120 at $2.21 | filing |
| 13 Dec 2022filed 23 Dec 2022 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $262120 at $2.18 | filing |
| 12 Dec 2022filed 23 Dec 2022 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $13965 at $2.14 | filing |
| 9 Dec 2022filed 23 Dec 2022 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $14065 at $2.15 | filing |
The newest 500 lines are listed; the numbers count every line.
News
Head to Head Review: Cumberland Pharmaceuticals (NASDAQ:CPIX) & Eloxx Pharmaceuticals (NASDAQ:ELOX)CPIX · dailypolitical.com · 17 Oct 2026Contrasting Lifecore Biomedical (NASDAQ:LFCR) & Cumberland Pharmaceuticals (NASDAQ:CPIX)CPIX · tickerreport.com · 13 Oct 2026
0 headlines in the last 90 days name Joseph C. Galante; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.